Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Cash Flow-to-Debt Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Cash Flow-to-Debt Ratio of 0.88x as of September 2025, meaning its operating cash flow of CN¥670.83 Million could theoretically repay 1% of its total liabilities (CN¥760.53 Million) in one year. See 688578 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Allist Pharmaceuticals Co. Ltd. A Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Shanghai Allist Pharmaceuticals Co. Ltd. A across 8 annual periods. Also explore 688578 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2024)
Year-by-year debt coverage analysis for Shanghai Allist Pharmaceuticals Co. Ltd. A. For market capitalisation and broader financial context, see how much is Shanghai Allist Pharmaceuticals Co. Ltd. worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 2.47x | CN¥1.57 Billion | CN¥633.32 Million | ▲ +44.5% |
| 2023 | 1.71x | CN¥674.65 Million | CN¥394.22 Million | ▲ +376.5% |
| 2022 | 0.36x | CN¥91.63 Million | CN¥255.12 Million | ▲ +92.5% |
| 2021 | 0.19x | CN¥29.29 Million | CN¥156.99 Million | ▲ +110.3% |
| 2020 | -1.80x | CN¥-196.75 Million | CN¥109.01 Million | ▼ -0.2% |
| 2019 | -1.80x | CN¥-259.37 Million | CN¥144.02 Million | ▼ -462.9% |
| 2018 | -0.32x | CN¥-97.25 Million | CN¥303.96 Million | ▼ -503.0% |
| 2017 | 0.08x | CN¥10.11 Million | CN¥127.37 Million | — |